This review outlines the indications for inotropic therapy in systolic heart failure, highlighting its utility as a bridge to advanced therapies or for palliation.
No takes yet. Share an insight, caveat, or question.
May guide inotrope use for stability or palliation in advanced HF; leaves open optimal agent and duration pending RCTs.
Tariq et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: